Gemifloxacin mesylate |
Factive |
Article: Gemifloxacin
| Image:Gemifloxacin.png | |
| Gemifloxacin | |
| Systematic (IUPAC) name | |
| 7-[(4Z)-3-(aminomethyl)- 4-methoxyimino-pyrrolidin-1-yl]- 1-cyclopropyl-6-fluoro-4-oxo- 1,8-naphthyridine-3-carboxylic acid | |
| Identifiers | |
| CAS number | 175463-14-6 |
| ATC code | J01MA15 |
| PubChem | 5464436 |
| DrugBank | APRD00053 |
| Chemical data | |
| Formula | C18H20FN5O4 |
| Mol. weight | 389.381 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 60-70% |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | |
| Routes | ? |
Gemifloxacin mesylate (Factive®, Oscient Pharmaceuticals) is an oral broad-spectrum quinolone antibacterial agent used in the treatment of acute bacterial exacerbation of chronic bronchitis and mild-to-moderate pneumonia.
Categories: Fluoroquinolone antibiotics | Pharmacology stubs

Not Signed In -


